Skip to main content

Table 6 In Vitro Drug Release of Caffeine and Folic acid

From: Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade

 

Release

Time

Caffeine

Folic acid

1 h

36.8 ± 3.6%

2.15 ± 0.37%

2 h

52.1 ± 3.04%

3.3 ± 0.3%

3 h

77.9 ± 4.37%

53 ± 3.9%

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us